AI Assistant
Blog
Pricing
Log In
Sign Up
Phase I study of EST, a new thiol protease inhibitor. The 2nd report: Safety and pharmacokinetics in continuous administration.
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
